Loading...
DiaSorin S.p.A.
DSRLF•PNK
HealthcareMedical - Diagnostics & Research
$104.69
$0.00(0.00%)
DiaSorin S.p.A. (DSRLF) Financial Performance & Statements
Review DiaSorin S.p.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
3.20%
↑ 3.20%
Operating Income Growth
9.56%
↑ 9.56%
Net Income Growth
17.68%
↑ 17.68%
Operating Cash Flow Growth
15.12%
↑ 15.12%
Operating Margin
23.04%
↑ 23.04%
Gross Margin
65.83%
↑ 65.83%
Net Profit Margin
16.40%
↑ 16.40%
ROE
9.17%
↑ 9.17%
ROIC
0.00%
DiaSorin S.p.A. (DSRLF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for DiaSorin S.p.A. stock.
Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
Revenue | $300.21M | $289.00M | $302.21M | $270.00M |
Cost of Revenue | $102.27M | $97.00M | $107.02M | $102.00M |
Gross Profit | $197.93M | $192.00M | $195.19M | $168.00M |
Gross Profit Ratio | $0.66 | $0.66 | $0.65 | $0.62 |
R&D Expenses | $21.23M | $22.00M | $22.95M | $22.00M |
SG&A Expenses | $103.96M | $102.00M | $111.41M | $100.00M |
Operating Expenses | $129.22M | $128.00M | $137.05M | $130.00M |
Total Costs & Expenses | $231.49M | $225.00M | $244.07M | $232.00M |
Interest Income | $0.00 | $0.00 | $1.92M | $6.00M |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $3.66M | $25.97M | $71.89M | $26.79M |
EBITDA | $74.56M | $63.00M | $81.48M | $48.00M |
EBITDA Ratio | $0.25 | $0.31 | $0.27 | $0.28 |
Operating Income | $70.90M | $64.00M | $55.51M | $49.00M |
Operating Income Ratio | $0.24 | $0.22 | $0.18 | $0.18 |
Other Income/Expenses (Net) | -$6.87M | -$5.00M | -$160.04M | -$16.00M |
Income Before Tax | $64.03M | $60.00M | $56.22M | $32.00M |
Income Before Tax Ratio | $0.21 | $0.21 | $0.19 | $0.12 |
Income Tax Expense | $14.53M | $14.00M | $9.71M | $7.00M |
Net Income | $50.006M | $46.00M | $47.85M | $25.00M |
Net Income Ratio | $0.17 | $0.16 | $0.16 | $0.09 |
EPS | $0.94 | $0.86 | $0.90 | $0.47 |
Diluted EPS | $0.94 | $0.86 | $0.90 | $0.47 |
Weighted Avg Shares Outstanding | $53.32M | $53.36M | $53.36M | $53.29M |
Weighted Avg Shares Outstanding (Diluted) | $53.32M | $53.36M | $53.36M | $53.29M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan